Followers | 262 |
Posts | 11356 |
Boards Moderated | 1 |
Alias Born | 08/01/2009 |
Thursday, June 01, 2017 8:33:35 PM
Hi Mark,
It doesn’t have to be loaded with facts. We are just looking for a concrete direction we are going which appears at this point in time not to be set in stone. We don’t necessarily need an exact time frame but what your hopes are for the company and in what time frame you hope to have the form 10/211 finalized and complete or the other path (exchange of shares with another shell). The back and forth between these two entities has me befuddled.
If the lawyer is not giving you the time of day IMO it is time to find another lawyer.
Without direction or planning there will never be closure as there is no goal. The goal would be a good place to start.
What is your goal? Having a goal as to the filing of a form 10/211 to FINRA and their writeoff (which has already been done as MIKP has been cleared for return to the pink sheets if I have comprehended this whole thing accurately). So in essence a current status with all filings in order would constitute return to the pink sheets and MIKP trading again.
Thanks Mark!
Tim
Recent MIKP News
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 11/28/2023 10:00:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/22/2023 06:06:28 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 07:00:35 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 11/02/2023 04:01:43 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/04/2023 04:01:33 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 08/23/2023 08:54:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/22/2023 06:10:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 01:07:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/28/2023 01:43:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM